好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Natalizumab and Risk of Melanoma: A Prospective Follow-Up of Patients Treated by Natalizumab for Multiple Sclerosis
MS and Related Diseases
(-)
115
Authors/Disclosures
No disclosure on file
No disclosure on file
No disclosure on file